Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.

AIMS/HYPOTHESIS: Juvenile-onset, insulin-dependent diabetes is associated with islet cell antibodies and with specific "high-risk" HLA-DRB1 and HLA-DQB1 genotypes. Patients with Type II (non-insulin-dependent) diabetes mellitus can have islet-related antibodies, but the genotypic associat...

Bibliografiset tiedot
Päätekijät:	Horton, V, Stratton, I, Bottazzo, G, Shattock, M, Mackay, I, Zimmet, P, Manley, S, Holman, R, Turner, R
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	1999

Samankaltaisia teoksia

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43)
Tekijä: Horton, V, et al.
Julkaistu: (1999)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
Tekijä: Turner, R, et al.
Julkaistu: (1997)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
Tekijä: Turner, R, et al.
Julkaistu: (1997)

Insulin VNTR and HLA DRB1/DQB1 LOCI affect age of presentation of autoimmune diabetes in adults
Tekijä: Horton, V, et al.
Julkaistu: (1998)

Ethnic differences in diabetic nephropathy - The UKPDS
Tekijä: Stevens, R, et al.
Julkaistu: (1999)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
Tekijä: Kohner, E, et al.
Julkaistu: (2001)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Tekijä: Matthews, DR, et al.
Julkaistu: (1998)

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
Tekijä: Davis, T, et al.
Julkaistu: (2005)

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
Tekijä: Bottazzo, G, et al.
Julkaistu: (2005)

GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.
Tekijä: Desai, M, et al.
Julkaistu: (2007)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
Tekijä: Turner, R, et al.
Julkaistu: (1991)

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
Tekijä: Kothari, V, et al.
Julkaistu: (2002)

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
Tekijä: Stevens, R, et al.
Julkaistu: (2001)

Risk factors for neuropathy in UKPDS
Tekijä: Stratton, I, et al.
Julkaistu: (2004)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
Tekijä: Cull, C, et al.
Julkaistu: (2001)

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
Tekijä: Alva, M, et al.
Julkaistu: (2014)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
Tekijä: Holman, R, et al.
Julkaistu: (2001)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
Tekijä: Clarke, P, et al.
Julkaistu: (2004)

UKPDS: what was the question? UK Prospective Diabetes Study.
Tekijä: Turner, R, et al.
Julkaistu: (1999)

UKPDS: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects
Tekijä: Widjaja, A, et al.
Julkaistu: (1996)

UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes.
Tekijä: Stevens, R, et al.
Julkaistu: (2002)

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.
Tekijä: Davis, T, et al.
Julkaistu: (1999)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
Tekijä: Holman, R
Julkaistu: (2007)

Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
Tekijä: Kohner, E, et al.
Julkaistu: (1999)

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
Tekijä: Turner, R, et al.
Julkaistu: (1998)

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (vol 48, pg 703, 2005)
Tekijä: Bottazzo, G, et al.
Julkaistu: (2005)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Tekijä: Adler, A, et al.
Julkaistu: (2003)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
Tekijä: Cull, C, et al.
Julkaistu: (2004)

UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.
Tekijä: Widjaja, A, et al.
Julkaistu: (1997)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
Tekijä: Stratton, I, et al.
Julkaistu: (2000)

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
Tekijä: Stratton, I, et al.
Julkaistu: (2001)

Forecasting coronary case fatality in type 2 diabetes: a UKPDS Risk Engine equation
Tekijä: Stevens, R, et al.
Julkaistu: (2002)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
Tekijä: Matthews, DR, et al.
Julkaistu: (1998)

Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.
Tekijä: Mehta, Z, et al.
Julkaistu: (1999)

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47).
Tekijä: Adler, A, et al.
Julkaistu: (1999)

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
Tekijä: Adler, A, et al.
Julkaistu: (2005)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
Tekijä: Coleman, R, et al.
Julkaistu: (2005)

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
Tekijä: Gray, A, et al.
Julkaistu: (2001)

The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results
Tekijä: Levy, J, et al.
Julkaistu: (1993)

[The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results]
Tekijä: Levy, J, et al.
Julkaistu: (1993)